retatrutide dosing clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP retatrutide clinical trial south korea

With more than two in five U.S

Do not use these medications if you have fever, bloody stools, or severe abdominal pain, and contact your doctor if symptoms persist beyond 48 hours

Every week, more patients ask about GLP-1 medications

MEDVi also offers brand-name options at premium pricing, which provides a potential pathway if compounded formulations become unavailable

So its left to nutritionists to pay even closer attention to risk factors and side effects for any clients using compounded GLP-1 treatments

While some individuals report symptom improvement, concerns remain regarding fiber deficiency, micronutrient gaps, cardiovascular risk markers, and gut microbiome health